Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Poerio, Angela"'
Autor:
Rosti, Gianantonio, Palandri, Francesca, Castagnetti, Fausto, Breccia, Massimo, Levato, Luciano, Gugliotta, Gabriele, Capucci, Adele, Cedrone, Michele, Fava, Carmen, Intermesoli, Tamara, Cambrin, Giovanna Rege, Stagno, Fabio, Tiribelli, Mario, Amabile, Marilina, Luatti, Simona, Poerio, Angela, Soverini, Simona, Testoni, Nicoletta, Martinelli, Giovanni, Alimena, Giuliana, Pane, Fabrizio, Saglio, Giuseppe, Baccarani, Michele, GIMEMA CML Working Party
Publikováno v:
In Blood 3 December 2009 114(24):4933-4938
Autor:
Iacobucci, Ilaria, Lonetti, Annalisa, Messa, Francesca, Cilloni, Daniela, Arruga, Francesca, Ottaviani, Emanuela, Paolini, Stefania, Papayannidis, Cristina, Piccaluga, Pier Paolo, Giannoulia, Panagiota, Soverini, Simona, Amabile, Marilina, Poerio, Angela, Saglio, Giuseppe, Pane, Fabrizio, Berton, Giorgio, Baruzzi, Anna, Vitale, Antonella, Chiaretti, Sabina, Perini, Giovanni, Foà, Robin, Baccarani, Michele, Martinelli, Giovanni
Publikováno v:
In Blood 1 November 2008 112(9):3847-3855
Autor:
Baccarani, Michele, Martinelli, Giovanni, Rosti, Gianantonio, Trabacchi, Elena, Testoni, Nicoletta, Bassi, Simona, Amabile, Marilina, Soverini, Simona, Castagnetti, Fausto, Cilloni, Daniela, Izzo, Barbara, de Vivo, Antonio, Messa, Emanuela, Bonifazi, Francesca, Poerio, Angela, Luatti, Simona, Giugliano, Emilia, Alberti, Daniele, Fincato, Gianluca, Russo, Domenico, Pane, Fabrizio, Saglio, Giuseppe
Publikováno v:
In Blood 15 December 2004 104(13):4245-4251
Autor:
Palandri, Francesca, Iacobucci, Ilaria, Castagnetti, Fausto, Testoni, Nicoletta, Poerio, Angela, Amabile, Marilina, Breccia, Massimo, Intermesoli, Tamara, Iuliano, Francesco, Rege Cambrin, Giovanna, Tiribelli, Mario, Miglino, Maurizio, Pane, Fabrizio, Saglio, Giuseppe, Martinelli, Giovanni, Rosti, Gianantonio, Baccarani, Michele, GIMEMA CML Working Party, Bocchia, Monica
Publikováno v:
Haematologica. 93:770-774
In 2004, we reported the short-term results of a multicentric, phase 2 study of imatinib 400 mg daily and pegylated interferon-alpha in the treatment of 76 early chronic phase Philadelphia-positive chronic myeloid leukemia patients. In this report, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b89ef090eb4fe1036e211b13f1f49aca
https://doi.org/10.3324/haematol.12265
https://doi.org/10.3324/haematol.12265
Autor:
Soverini, Simona, Gnani, Alessandra, Colarossi, Sabrina, Vitale, Antonella, Castagnetti, Fausto, FRANCESCA PALANDRI, Paolini, Stefania, Papayannidis, Cristina, Amabile, Marilina, Lacobucci, Ilaria, Poerio, Angela, Scotlandi, Katia, Lonetti, Annalisa, Mandelli, Franco, Baccarani, Michele, Foa, Robin, Martinelli, Giovanni
Publikováno v:
Web of Science
Mutations in the Bcr-Abl kinase domain (KD) are often detected at the time of resistance to tyrosine kinase inhibitor (TKI) therapy in chronic myeloid leukemia (CML) and Philadelphia-positive (Ph+) acute lymphoblastic leukemia (ALL) patients (pts). I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bc06a83c1e416f120c65c05efa99231c
http://hdl.handle.net/11585/604963
http://hdl.handle.net/11585/604963
Autor:
Palandri, Francesca, Iacobucci, Ilaria, Martinelli, Giovanni, Amabile, Marilina, Poerio, Angela, Testoni, Nicoletta, Soverini, Simona, Castagnetti, Fausto, De Vivo, Antonio, Breccia, Massimo, Specchia, Giorgina, Abruzzese, Elisabetta, Martino, Bruno, Cilloni, Daniela, Saglio, Giuseppe, Pane, Fabrizio, Liberati, Anna Marina, Rosti, Gianantonio, Baccarani, Michele, GIMEMA CML Working Party, Bocchia, Monica
Purpose Imatinib mesylate (IM) has rapidly become the front-line treatment of Philadelphia-positive (Ph-pos) chronic myeloid leukemia, but the number of patients who were treated and are being treated with IM second-line is still substantial. Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8e1101b4618cdc93fb0b9e3368aed16
http://hdl.handle.net/11588/342491
http://hdl.handle.net/11588/342491
Autor:
Rosti, Gianantonio, Iacobucci, Ilaria, Bassi, Simona, Castagnetti, Fausto, Amabile, Marilina, Cilloni, Daniela, Poerio, Angela, Soverini, Simona, Palandri, Francesca, Rege Cambrin, Giovanna, Iuliano, Franco, Alimena, Giuliana, Latagliata, Roberto, Testoni, Nicoletta, Pane, Fabrizio, Saglio, Giuseppe, Baccarani, Michele, Martinelli, Giovanni, GIMEMA CML Working Party, Bocchia, Monica
To assess the effect of age on response and compliance to treatment in patients with chronic myeloid leukemia (CML) we performed a sub-analysis within a phase II trial of the GIMEMA CML Working Party (CML/002/STI571). Since the WHO cut-off age to def
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e43363f028f1182a9a17b2f57dd4dfec
http://hdl.handle.net/11585/43895
http://hdl.handle.net/11585/43895
Autor:
SOVERINI, SIMONA, COLAROSSI, SABRINA, GNANI, ALESSANDRA, ROSTI, GIANANTONIO, CASTAGNETTI, FAUSTO, POERIO, ANGELA, IACOBUCCI, ILARIA, AMABILE, MARILINA, BACCARANI, MICHELE, MARTINELLI, GIOVANNI, Abruzzese E, Orlandi E, Radaelli F, Ciccone F, Tiribelli M, di Lorenzo R, Caracciolo C, Izzo B, Pane F, Saglio G, on behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia
Purpose: ABL kinase domain mutations have been implicated in the resistance to the BCR-ABL inhibitor imatinib mesylate of Philadelphia-positive (Ph+) leukemia patients. Experimental Design: Using denaturing high-performance liquid chromatography and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6ca62e5cfbf4dcb7dfb32271a214cf7
http://hdl.handle.net/11588/108687
http://hdl.handle.net/11588/108687
Autor:
SOVERINI, SIMONA, TASCO, GIANLUCA, GRAFONE, TIZIANA, COLAROSSI, SABRINA, ROSTI, GIANANTONIO, CASTAGNETTI, FAUSTO, PALANDRI, FRANCESCA, RONDONI, MICHELA, POERIO, ANGELA, IACOBUCCI, ILARIA, AMABILE, MARILINA, BACCARANI, MICHELE, CASADIO, RITA, MARTINELLI, GIOVANNI, Gnani A.
Background. SKI-606 is a novel 4-anilino-3-quinolinecarbonitrile Src and Abl kinase inhibitor. SKI-606 has been shown to be a potent antiproliferative and proapoptotic agent when tested on Bcr-Abl-positive cell lines. The remarkable efficacy of SKI-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4094::77221a1e91a2e33afcdea53e2c2e1be9
http://hdl.handle.net/11585/35288
http://hdl.handle.net/11585/35288